Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 28

    1.

    Evaluation of different methods for assessment of insulin sensitivity in Gottingen minipigs: introduction of a new, simpler method.

    Christoffersen B, Ribel U, Raun K, Golozoubova V, Pacini G.

    Am J Physiol Regul Integr Comp Physiol. 2009 Oct;297(4):R1195-201. Epub 2009 Aug 26.PMID: 19710388 [PubMed - indexed for MEDLINE]Related articles

    2.

    Simply perfect.

    Raun KJ.

    JEMS. 2007 Nov;32(11):16; author reply 16. No abstract available. PMID: 17983904 [PubMed - indexed for MEDLINE]Related articles

    3.

    Gender-associated differences in metabolic syndrome-related parameters in Göttingen minipigs.

    Christoffersen BO, Grand N, Golozoubova V, Svendsen O, Raun K.

    Comp Med. 2007 Oct;57(5):493-504.PMID: 17974133 [PubMed - indexed for MEDLINE]Related articles

    4.

    Evaluation of beta-cell mass and function in the Göttingen minipig.

    Larsen MO, Rolin B, Raun K, Bjerre Knudsen L, Gotfredsen CF, Bock T.

    Diabetes Obes Metab. 2007 Nov;9 Suppl 2:170-9.PMID: 17919191 [PubMed - indexed for MEDLINE]Related articles

    5.

    Liraglutide, a once-daily human glucagon-like peptide-1 analog, minimizes food intake in severely obese minipigs.

    Raun K, von Voss P, Knudsen LB.

    Obesity (Silver Spring). 2007 Jul;15(7):1710-6.PMID: 17636089 [PubMed - indexed for MEDLINE]Related articles

    6.

    Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not.

    Raun K, von Voss P, Gotfredsen CF, Golozoubova V, Rolin B, Knudsen LB.

    Diabetes. 2007 Jan;56(1):8-15.PMID: 17192459 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Evalution of the castrated male Sprague-Dawley rat as a model of the metabolic syndrome and type 2 diabetes.

    Christoffersen B, Raun K, Svendsen O, Fledelius C, Golozoubova V.

    Int J Obes (Lond). 2006 Aug;30(8):1288-97. Epub 2006 Feb 28.PMID: 16505834 [PubMed - indexed for MEDLINE]Related articles

    8.

    PYY3-36 as an anti-obesity drug target.

    Boggiano MM, Chandler PC, Oswald KD, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Schindler M, Arndt K, Rudolf K, Mark M, Schoelch C, Joost HG, Klaus S, Thöne-Reineke C, Benoit SC, Seeley RJ, Beck-Sickinger AG, Koglin N, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Deng XY, Whitcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Ortmann S, Castañeda TR, Tschöp M.

    Obes Rev. 2005 Nov;6(4):307-22. Review.PMID: 16246216 [PubMed - indexed for MEDLINE]Related articles

    9.

    Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight.

    Malmlöf K, Zaragoza F, Golozoubova V, Refsgaard HH, Cremers T, Raun K, Wulff BS, Johansen PB, Westerink B, Rimvall K.

    Int J Obes (Lond). 2005 Dec;29(12):1402-12.PMID: 16151415 [PubMed - indexed for MEDLINE]Related articles

    10.

    Physiology: does gut hormone PYY3-36 decrease food intake in rodents?

    Tschöp M, Castañeda TR, Joost HG, Thöne-Reineke C, Ortmann S, Klaus S, Hagan MM, Chandler PC, Oswald KD, Benoit SC, Seeley RJ, Kinzig KP, Moran TH, Beck-sickinger AG, Koglin N, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Schindler M, Arndt K, Rudolf K, Mark M, Deng XY, Whitcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Craney S, Flora D, Smiley D, Heiman ML.

    Nature. 2004 Jul 8;430(6996):1 p following 165; discussion 2 p following 165. Erratum in: Nature. 2004 Sep 23;431(7007):1038. Withcomb, DC [corrected to Whitcomb, DC]. PMID: 15243972 [PubMed - indexed for MEDLINE]Related articles

    11.

    Homologous growth hormone accelerates bone healing--a biomechanical and histological study.

    Kolbeck S, Bail H, Schmidmaier G, Alquiza M, Raun K, Kappelgard A, Flyvbjerg A, Haas N, Raschke M.

    Bone. 2003 Oct;33(4):628-37.PMID: 14555268 [PubMed - indexed for MEDLINE]Related articles

    12.

    Absorption and systemic availability of two synthetic growth hormone secretogogues and transport of glucose by the proximal small intestine of anestrus dogs after administering estradiol.

    Nielsen KK, Buddington KK, Raun K, Hansen TK, Buddington RK.

    J Comp Physiol B. 2003 Feb;173(1):61-7. Epub 2003 Jan 9.PMID: 12592444 [PubMed - indexed for MEDLINE]Related articles

    13.

    Physiology of meiosis-activating sterol: endogenous formation and mode of action.

    Grøndahl C, Breinholt J, Wahl P, Murray A, Hansen TH, Faerge I, Stidsen CE, Raun K, Hegele-Hartung C.

    Hum Reprod. 2003 Jan;18(1):122-9.PMID: 12525452 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Ultrasound can predict regenerate stiffness in distraction osteogenesis.

    Bail HJ, Kolbeck S, Krummrey G, Weiler A, Windhagen HJ, Hennies K, Raun K, Raschke MJ.

    Clin Orthop Relat Res. 2002 Nov;(404):362-7.PMID: 12439281 [PubMed - indexed for MEDLINE]Related articles

    15.

    The influence of conformational restriction in the C-terminus of growth hormone secretagogues on their potency.

    Peschke B, Ankersen M, Bauer M, Hansen TK, Hansen BS, Nielsen KK, Raun K, Richter L, Westergaard L.

    Eur J Med Chem. 2002 Jun;37(6):487-501.PMID: 12204475 [PubMed - indexed for MEDLINE]Related articles

    16.

    Recombinant species-specific growth hormone increases hard callus formation in distraction osteogenesis.

    Bail HJ, Raschke MJ, Kolbeck S, Krummrey G, Windhagen HJ, Weiler A, Raun K, Mosekilde L, Haas NP.

    Bone. 2002 Jan;30(1):117-24.PMID: 11792573 [PubMed - indexed for MEDLINE]Related articles

    17.

    The effect of growth hormone on insulin-like growth factor I and bone metabolism in distraction osteogenesis.

    Bail HJ, Kolbeck S, Lindner T, Dahne M, Weiler A, Windhagen HJ, Raun K, Skjaerbaek C, Flyvbjerg A, Ørskov H, Haas NP, Raschke MJ.

    Growth Horm IGF Res. 2001 Oct;11(5):314-23.PMID: 11735250 [PubMed - indexed for MEDLINE]Related articles

    18.

    Highly potent growth hormone secretagogues: hybrids of NN703 and ipamorelin.

    Hansen TK, Ankersen M, Raun K, Hansen BS.

    Bioorg Med Chem Lett. 2001 Jul 23;11(14):1915-8.PMID: 11459660 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Recombinant growth hormone accelerates regenerate consolidation in distraction osteosynthesis]

    Raschke MJ, Kolbeck SF, Dahne M, Lindner T, Raun K, Bail H.

    Chirurg. 2000 Sep;71(9):1009-15. German. PMID: 11043117 [PubMed - indexed for MEDLINE]Related articles

    20.

    New highly potent dipeptidic growth hormone secretagogues with low molecular weight.

    Peschke B, Ankersen M, Hansen TK, Hansen BS, Lau J, Nielsen KK, Raun K.

    Eur J Med Chem. 2000 Jun;35(6):599-618.PMID: 10906412 [PubMed - indexed for MEDLINE]Related articles

    21.

    Growth hormone secretagogues derived from NN703 with hydrazidesas c-terminal.

    Ankersen M, Kramer Nielsen K, Kruse Hansen T, Raun K, Sehested Hansen B.

    Eur J Med Chem. 2000 May;35(5):487-97.PMID: 10889328 [PubMed - indexed for MEDLINE]Related articles

    22.

    Pharmacological characterisation of a new oral GH secretagogue, NN703.

    Hansen BS, Raun K, Nielsen KK, Johansen PB, Hansen TK, Peschke B, Lau J, Andersen PH, Ankersen M.

    Eur J Endocrinol. 1999 Aug;141(2):180-9.PMID: 10427162 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Recombinant growth hormone accelerates bone regenerate consolidation in distraction osteogenesis.

    Raschke MJ, Bail H, Windhagen HJ, Kolbeck SF, Weiler A, Raun K, Kappelgard A, Skiaerbaek C, Haas NP.

    Bone. 1999 Feb;24(2):81-8.PMID: 9951774 [PubMed - indexed for MEDLINE]Related articles

    24.

    Ipamorelin, the first selective growth hormone secretagogue.

    Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH.

    Eur J Endocrinol. 1998 Nov;139(5):552-61.PMID: 9849822 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Novel orally active growth hormone secretagogues.

    Hansen TK, Ankersen M, Hansen BS, Raun K, Nielsen KK, Lau J, Peschke B, Lundt BF, Thøgersen H, Johansen NL, Madsen K, Andersen PH.

    J Med Chem. 1998 Sep 10;41(19):3705-14.PMID: 9733496 [PubMed - indexed for MEDLINE]Related articles

    26.

    A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.

    Ankersen M, Johansen NL, Madsen K, Hansen BS, Raun K, Nielsen KK, Thogersen H, Hansen TK, Peschke B, Lau J, Lundt BF, Andersen PH.

    J Med Chem. 1998 Sep 10;41(19):3699-704.PMID: 9733495 [PubMed - indexed for MEDLINE]Related articles

    27.

    Follicle aspiration in the mare using a transvaginal ultrasound-guided technique.

    Brück I, Raun K, Synnestvedt B, Greve T.

    Equine Vet J. 1992 Jan;24(1):58-9. No abstract available. PMID: 1555542 [PubMed - indexed for MEDLINE]Related articles

    28.

    Respiratory tract distribution and bioavailability of spiramycin in calves.

    Friis C, Erhardsen E, Madsen EB, Nielsen P, Raun K.

    Am J Vet Res. 1991 Aug;52(8):1269-73.PMID: 1928908 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...